{"name": "BiPar Sciences",
 "permalink": "bipar-sciences",
 "crunchbase_url": "http://www.crunchbase.com/company/bipar-sciences",
 "homepage_url": "http://www.biparsciences.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": null,
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2002,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "biotech, cancer, therapeutics",
 "alias_list": "",
 "email_address": "",
 "phone_number": "(650) 635-6050",
 "description": "PARP Inhibitors (Cancer Therapeutics)",
 "created_at": "Wed Apr 22 01:30:09 UTC 2009",
 "updated_at": "Mon Aug 22 01:28:33 UTC 2011",
 "overview": "\u003Cp\u003EBiPar Sciences Inc. is a Brisbane, CA based developer of PARP inhibitors as cancer therapies. BiPar\u0026#8217;s key experimental product is BSI-201, currently in mid-stage trials for advanced breast cancer, ovarian cancer and other tumors.\u003C/p\u003E\n\n\u003Cp\u003EBiPar has raised around $60 million in VC funding, from firms like \u003Ca href=\"/financial-organization/domain-associates\" title=\"Domain Associates\" rel=\"nofollow\"\u003EDomain Associates\u003C/a\u003E, \u003Ca href=\"/financial-organization/canaan-partners-3\" title=\"Canaan Partners\" rel=\"nofollow\"\u003ECanaan Partners\u003C/a\u003E, \u003Ca href=\"/financial-organization/vulcan-capital\" title=\"Vulcan Capital\" rel=\"nofollow\"\u003EVulcan Capital\u003C/a\u003E, \u003Ca href=\"/financial-organization/polytechnos-venture-partners\" title=\"PolyTechnos Venture Partners\" rel=\"nofollow\"\u003EPolyTechnos Venture Partners\u003C/a\u003E, \u003Ca href=\"/financial-organization/asset-management\" title=\"Asset Management Company\" rel=\"nofollow\"\u003EAsset Management Company\u003C/a\u003E, and \u003Ca href=\"/financial-organization/quantum-technology-partners\" title=\"Quantum Technology Partners\" rel=\"nofollow\"\u003EQuantum Technology Partners\u003C/a\u003E. It also has raised venture debt from \u003Ca href=\"/financial-organization/lighthouse-capital-partners\" title=\"Lighthouse Capital Partners\" rel=\"nofollow\"\u003ELighthouse Capital Partners\u003C/a\u003E.\u003C/p\u003E\n\n\u003Cp\u003EOn April 15th, 2009, French drug maker \u003Ca href=\"/company/sanofi-aventis-2\" title=\"Sanofi-Aventis S.A.\" rel=\"nofollow\"\u003ESanofi-Aventis S.A.\u003C/a\u003E announced it was acquiring BiPar Sciences for up to $500 million. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[140,
       62],
      "assets/images/resized/0004/2189/42189v1-max-150x150.png"],
     [[140,
       62],
      "assets/images/resized/0004/2189/42189v1-max-250x250.png"],
     [[140,
       62],
      "assets/images/resized/0004/2189/42189v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [{"name": "BSI-201",
    "permalink": "bsi-201",
    "image": null}],
 "relationships":
  [{"is_past": false,
    "title": "Chief Financial Officer",
    "person":
     {"first_name": "John",
      "last_name": "Schembri",
      "permalink": "john-schembri",
      "image": null}},
   {"is_past": false,
    "title": "President and Chief Executive Officer",
    "person":
     {"first_name": "Hoyoung",
      "last_name": "Huh, M.D., Ph.D.",
      "permalink": "hoyoung-huh-m-d-ph-d",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Regulatory Affairs",
    "person":
     {"first_name": "Deborah A.",
      "last_name": "Thomas, Ph.D.",
      "permalink": "deborah-a-thomas-ph-d",
      "image": null}},
   {"is_past": false,
    "title": "Executive Vice President, Development",
    "person":
     {"first_name": "Barry",
      "last_name": "Sherman, M.D.",
      "permalink": "barry-sherman-m-d",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Clinical Development",
    "person":
     {"first_name": "Charles",
      "last_name": "Bradley, Ph.D.",
      "permalink": "charles-bradley-ph-d",
      "image": null}},
   {"is_past": false,
    "title": "Corporate Development and Marketing",
    "person":
     {"first_name": "Sunil",
      "last_name": "Patel",
      "permalink": "sunil-patel",
      "image": null}},
   {"is_past": true,
    "title": "Board Member",
    "person":
     {"first_name": "Wende",
      "last_name": "Hutton",
      "permalink": "wende-hutton",
      "image":
       {"available_sizes":
         [[[127,
            150],
           "assets/images/resized/0026/0392/260392v1-max-150x150.jpg"],
          [[150,
            176],
           "assets/images/resized/0026/0392/260392v1-max-250x250.jpg"],
          [[150,
            176],
           "assets/images/resized/0026/0392/260392v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$73M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.biparsciences.com/000019.html?n=33",
    "source_description": "BiPar Sciences Raises $13 Million in Series A Financing",
    "raised_amount": 13000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2004,
    "funded_month": 12,
    "funded_day": 20,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Vulcan Capital",
         "permalink": "vulcan-capital",
         "image":
          {"available_sizes":
            [[[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-150x150.png"],
             [[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-250x250.png"],
             [[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quantum Technology Partners",
         "permalink": "quantum-technology-partners",
         "image":
          {"available_sizes":
            [[[133,
               74],
              "assets/images/resized/0005/2883/52883v1-max-150x150.png"],
             [[133,
               74],
              "assets/images/resized/0005/2883/52883v1-max-250x250.png"],
             [[133,
               74],
              "assets/images/resized/0005/2883/52883v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "PolyTechnos Venture Partners",
         "permalink": "polytechnos-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0003/1542/31542v1-max-150x150.png"],
             [[186,
               72],
              "assets/images/resized/0003/1542/31542v1-max-250x250.png"],
             [[186,
               72],
              "assets/images/resized/0003/1542/31542v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Asset Management Company",
         "permalink": "asset-management",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0001/9262/19262v1-max-150x150.png"],
             [[250,
               41],
              "assets/images/resized/0001/9262/19262v1-max-250x250.png"],
             [[377,
               62],
              "assets/images/resized/0001/9262/19262v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Canaan Partners",
         "permalink": "canaan-partners-3",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0000/3958/3958v4-max-150x150.jpg"],
             [[250,
               82],
              "assets/images/resized/0000/3958/3958v4-max-250x250.jpg"],
             [[450,
               147],
              "assets/images/resized/0000/3958/3958v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.biparsciences.com/000019.html?n=28",
    "source_description": "BiPar Sciences Raises $35 Million to Advance Pipeline of Novel PARP Inhibitor Cancer Drug Candidates",
    "raised_amount": 35000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 2,
    "funded_day": 26,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Domain Associates",
         "permalink": "domain-associates",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0003/2807/32807v1-max-150x150.png"],
             [[250,
               121],
              "assets/images/resized/0003/2807/32807v1-max-250x250.png"],
             [[264,
               128],
              "assets/images/resized/0003/2807/32807v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Vulcan Capital",
         "permalink": "vulcan-capital",
         "image":
          {"available_sizes":
            [[[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-150x150.png"],
             [[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-250x250.png"],
             [[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Canaan Partners",
         "permalink": "canaan-partners-3",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0000/3958/3958v4-max-150x150.jpg"],
             [[250,
               82],
              "assets/images/resized/0000/3958/3958v4-max-250x250.jpg"],
             [[450,
               147],
              "assets/images/resized/0000/3958/3958v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "PolyTechnos Venture Partners",
         "permalink": "polytechnos-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0003/1542/31542v1-max-150x150.png"],
             [[186,
               72],
              "assets/images/resized/0003/1542/31542v1-max-250x250.png"],
             [[186,
               72],
              "assets/images/resized/0003/1542/31542v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Asset Management Company",
         "permalink": "asset-management",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0001/9262/19262v1-max-150x150.png"],
             [[250,
               41],
              "assets/images/resized/0001/9262/19262v1-max-250x250.png"],
             [[377,
               62],
              "assets/images/resized/0001/9262/19262v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quantum Technology Partners",
         "permalink": "quantum-technology-partners",
         "image":
          {"available_sizes":
            [[[133,
               74],
              "assets/images/resized/0005/2883/52883v1-max-150x150.png"],
             [[133,
               74],
              "assets/images/resized/0005/2883/52883v1-max-250x250.png"],
             [[133,
               74],
              "assets/images/resized/0005/2883/52883v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.biparsciences.com/000019.html?n=35",
    "source_description": "BiPar Sciences Raises $20 Million to Advance Clinical Programs",
    "raised_amount": 20000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 1,
    "funded_day": 12,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Vulcan Capital",
         "permalink": "vulcan-capital",
         "image":
          {"available_sizes":
            [[[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-150x150.png"],
             [[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-250x250.png"],
             [[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Canaan Partners",
         "permalink": "canaan-partners-3",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0000/3958/3958v4-max-150x150.jpg"],
             [[250,
               82],
              "assets/images/resized/0000/3958/3958v4-max-250x250.jpg"],
             [[450,
               147],
              "assets/images/resized/0000/3958/3958v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Asset Management Company",
         "permalink": "asset-management",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0001/9262/19262v1-max-150x150.png"],
             [[250,
               41],
              "assets/images/resized/0001/9262/19262v1-max-250x250.png"],
             [[377,
               62],
              "assets/images/resized/0001/9262/19262v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Domain Associates",
         "permalink": "domain-associates",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0003/2807/32807v1-max-150x150.png"],
             [[250,
               121],
              "assets/images/resized/0003/2807/32807v1-max-250x250.png"],
             [[264,
               128],
              "assets/images/resized/0003/2807/32807v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "PolyTechnos Venture Partners",
         "permalink": "polytechnos-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0003/1542/31542v1-max-150x150.png"],
             [[186,
               72],
              "assets/images/resized/0003/1542/31542v1-max-250x250.png"],
             [[186,
               72],
              "assets/images/resized/0003/1542/31542v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quantum Technology Partners",
         "permalink": "quantum-technology-partners",
         "image":
          {"available_sizes":
            [[[133,
               74],
              "assets/images/resized/0005/2883/52883v1-max-150x150.png"],
             [[133,
               74],
              "assets/images/resized/0005/2883/52883v1-max-250x250.png"],
             [[133,
               74],
              "assets/images/resized/0005/2883/52883v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "debt_round",
    "source_url": "http://www.biparsciences.com/000019.html?n=31",
    "source_description": "BiPar Sciences Announces $5 Million Financing to Accelerate BSI-201 Clinical Program",
    "raised_amount": 5000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 6,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Lighthouse Capital Partners",
         "permalink": "lighthouse-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               62],
              "assets/images/resized/0002/9753/29753v1-max-150x150.jpg"],
             [[199,
               83],
              "assets/images/resized/0002/9753/29753v1-max-250x250.jpg"],
             [[199,
               83],
              "assets/images/resized/0002/9753/29753v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 500000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://online.wsj.com/article/SB123979301485720613.html",
   "source_description": "Sanofi to Buy BiPar Sciences ",
   "acquired_year": 2009,
   "acquired_month": 4,
   "acquired_day": 15,
   "acquiring_company":
    {"name": "Sanofi Aventis",
     "permalink": "sanofi-aventis-2",
     "image":
      {"available_sizes":
        [[[150,
           119],
          "assets/images/resized/0005/4534/54534v3-max-150x150.png"],
         [[150,
           119],
          "assets/images/resized/0005/4534/54534v3-max-250x250.png"],
         [[150,
           119],
          "assets/images/resized/0005/4534/54534v3-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "Headquarters",
    "address1": "1000 Marina Blvd.",
    "address2": "Suite 550",
    "zip_code": "94005",
    "city": "Brisbane",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.674378,
    "longitude": -122.387699}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}